UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC
Clinical trials for UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC explained in plain language.
Never miss a new study
Get alerted when new UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC trials appear
Sign up with your email to follow new studies for UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Low-Oxygen cancers in early trial
Disease control Recruiting nowThis study tests a new drug called CP-506, which becomes active only in low-oxygen areas of solid tumors. It is given alone or with chemotherapy (carboplatin) or immunotherapy. The goal is to find safe doses and see if it helps control tumor growth. About 126 adults with advanced…
Matched conditions: UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC
Phase: PHASE1, PHASE2 • Sponsor: Maastricht University Medical Center • Aim: Disease control
Last updated May 17, 2026 08:04 UTC
-
DNA detective: can tumor profiling unlock better cancer care?
Knowledge-focused Recruiting nowThis study looks at whether analyzing the DNA of a tumor can help doctors recommend more effective treatments for people with advanced cancer that has spread. Researchers will check if they can find genetic changes that match existing drugs or experimental therapies. The goal is …
Matched conditions: UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC
-
20,000 tumor samples to fuel Tomorrow's cancer breakthroughs
Knowledge-focused Recruiting nowThis study collects blood and tissue samples from 20,000 people with suspected solid tumors. The samples are stored in a central bank for researchers to use in future studies. The goal is to help scientists better understand cancer and develop new treatments. Participation involv…
Matched conditions: UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 11, 2026 20:37 UTC